An increase in the number of microglia during the later stage of neurodegeneration can be observed as a biomarker in AD with increasing SIRT5, whose function contrasts with the neuroprotective functions of SIRT1 and SIRT3 [69]. The gene discussed is SIRT1; the disease is Alzheimer disease.